| [1] |
LIANG Damin, YANG Zhengjiu, ZHANG Ziping, QIAN Jing, MAO Chaokun.
Study on the effect and mechanism of kaempferol in reversing drug-resistant Bel-7402/5-Fu cells
[J]. Tianjin Medical Journal, 2024, 52(9): 900-906.
|
| [2] |
WANG Yuanzhen, WEI Hongyan, CHANG Lixian, ZHANG Yingyuan, LIU Chunyun, LIU Li.
Establishment and validation of a risk prediction model for primary liver cancer complicated with pulmonary infection before intervention
[J]. Tianjin Medical Journal, 2024, 52(9): 940-945.
|
| [3] |
WU Jing, FAN Zhijuan, LIU Shuye.
Changes and clinical significance of plasma free amino acid levels in the development of chronic hepatitis B to hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2024, 52(7): 738-742.
|
| [4] |
LIU Xiaoyan, BU Rui, LU Jianfei, DING Yu, ZHANG Xing.
Value of Sonazoid contrast-enhanced ultrasound for preoperatively evaluating pathological grade of hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2024, 52(6): 658-662.
|
| [5] |
NING Yinkuan, LIU Linzhi, CHEN Xianping.
Experimental study on the mineralization of rabbit bone marrow mesenchymal stem cells after transfection with BMP2 recombinant lentivirus
[J]. Tianjin Medical Journal, 2023, 51(5): 454-459.
|
| [6] |
WU Qiong, LI Jinyuan, HUANG Wentao, AN Na.
Effects of acacetin on proliferation, apoptosis and migration of hepatocellular carcinoma HepG2 cells and its mechanism
[J]. Tianjin Medical Journal, 2023, 51(3): 235-239.
|
| [7] |
TANG Haoyan, PAN Zhenglong, LIU Xiaofang.
Association between single nucleotide polymorphism of TP53 gene and prognosis of primary hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2023, 51(11): 1249-1254.
|
| [8] |
REN Zhixing, YANG Guanghua.
Study on the mechanism of CDCA8 promoting the occurrence of prostate cancer by regulating proliferation
[J]. Tianjin Medical Journal, 2022, 50(8): 796-801.
|
| [9] |
LYU Kangning, , WANG Lei, QIN Song, WANG Li△.
Research progress of the protective effect and mechanism of C-phycocyanin on liver injury
[J]. Tianjin Medical Journal, 2022, 50(6): 668-672.
|
| [10] |
TAN Yuying, ZHANG Weiqi, XIE Yan, LI Jiang, LI Junjie, JIANG Wentao△.
The risk factor analysis and predictive model construction of microvascular invasion in hepatocellular carcinoma
[J]. Tianjin Medical Journal, 2022, 50(5): 523-527.
|
| [11] |
YU Kuiyang, LIU Pan, ZHANG Haowen, QIN Tao, HU Mingxing△.
Study on the mechanism of LncRNA ZFAS1 targeting miR-373 to induce cisplatin resistance in hepatocellular carcinoma cells
[J]. Tianjin Medical Journal, 2022, 50(5): 455-460.
|
| [12] |
LIU Shuaibing, YAN Mo, WANG Kaibin, YANG Kuo, WANG Yuzhuo.
The expression and significance of GPR19 gene in prostate cancer
[J]. Tianjin Medical Journal, 2022, 50(11): 1128-1133.
|
| [13] |
LIN Jie, WANG Wei-dong, OU Huo-hui, HE Wei, CHEN Jian-ping, MA Jing, ZUO Hai-bo, LIU Qing-bo.
The inhibitory effect of CLEC5A on cell proliferation and metastasis in intrahepatic
cholangiocarcinoma
[J]. Tianjin Medical Journal, 2021, 49(7): 678-682.
|
| [14] |
LIU Cui-lan, LI Jian-jun, ZHAO Di, LI Cheng-long, QIU Chang-yun, LIU Song.
The regulatory effects and mechanism of urolithin C on biological behaviors of glioblastoma
[J]. Tianjin Medical Journal, 2021, 49(11): 1126-1132.
|
| [15] |
XU Yang, XIAO Bin , WEI Mei , DAI Rong-yang , XIANG Yuan-cai △.
Baicalin inhibits human cholangiocarcinoma cell proliferation via regulating c-Myc mediated cell cycle#br#
[J]. Tianjin Medical Journal, 2020, 48(8): 705-710.
|